Ignite Creation Date:
2024-05-06 @ 6:36 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05727267
Status:
RECRUITING
Last Update Posted:
2024-02-09
First Post:
2022-11-06
Brief Title:
A Heterologous Protein PrimeMVA Boost Therapeutic Hepatitis B Vaccine Candidate
Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Organization:
Universitätsklinikum Hamburg-Eppendorf
Organization Data
Organization:
Universitätsklinikum Hamburg-Eppendorf
Class:
OTHER
Study ID:
TherVacB_Phase1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Universitätsklinikum Hamburg-Eppendorf
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Monipol Deutschland GmbH | UNKNOWN |
| German Center for Infection Research | OTHER |
| Medical Biometry and Epidemiology_- Universitätsklinikum Hamburg Eppendorf | UNKNOWN |
| Helmholtz Zentrum München | INDUSTRY |
| Fraunhofer Gesellschaft | UNKNOWN |
| Institute of Virology Helmholtz Zentrum München HMGU | UNKNOWN |
| LMU Klinikum | OTHER |